Prefilled Syringes Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024
Report ID: GMI1968
Prefilled Syringes Market size is expected to foresee substantial growth from 2017 to 2024.
Prefilled syringes market size should experience significant growth due to added advantages over the traditional vial and ampoules. Reduced dose error and ease of use are the two major advantages associated with the prefilled syringes. The method is increasingly preferred by most of the pharmaceutical companies as less overfill in prefilled syringes compared to traditional vials are advantageous for them.
The prefilled syringes allow the self-administration of the drugs at patients’ home, increase the product life span and minimizes the drug wastage. The product has wide applicability and can be used to deliver therapeutic proteins, erythropoietin, vaccines, and blood stimulants. Aforementioned advantages will fuel the prefilled syringes market momentum over forecast period.
Ongoing technological advancements focused at developing safe and convenient injectables with wide applicability should have positive influence. For instance, some of the latest innovation in the field includes use of electron beam sterilization tunnels to increase the safety associated and non-destructive control and inspection advances with cold chain management to minimize wastage of active pharma ingredients.
The use of prefilled syringes saves the time by eliminating the tedious process of transferring the drugs from container to syringe which can be of immense help in emergency situations. This alternative technology helps in the better management of chronic diseases like diabetes and rheumatoid arthritis. Increasing prevalence of such chronic diseases will serve to be a high impact rendering factor.
Limitations such as stability concerns, possibility of interaction with drug, and stability issues associated with the prefilled syringes should limit the market growth. The manufactures must ensure that primary packaging do not react with the drug and materials used are free from extractable.
The choice of material to be used for manufacturing is widely depends on the drug and patients need. Glass is most widely used owing to the regulatory ease and excellent barrier properties. However, use of polymer is expected to grow in near future due to the inert properties and good stability. The extensive design options with the polymers is an added advantage.
Diabetes application segment should witness significant growth due to increasing prevalence of the diseases. Error in the insulin administration may lead to death within 48 hours owing to which the demand for safer injection techniques is increasing. The commercially available prefilled syringes of insulin allow safer administration of insulin with accurate dosage.
As per WHO, around 1.3 million people die every year due to needle stick and blood borne pathogen, unsafe injection practices and sharing and reuse of needles. Such increasing incidences are driving the demand for safer alternative drug delivery technologies by hospitals boosting the hospital end-use segment growth over forecast timeframe.
U.S. will witness significant growth due to increasing incidences of chronic diseases and increasing demand for safe injection practices. Over the last decade around 150,000 patients in the country were exposed to the infectious diseases like HIV, hepatitis B virus and hepatitis C virus due to the errors in injection practices. Rising incidences of infection and technological advancements in the region will influence the prefilled syringes market. Increasing incidences of chronic diseases coupled with the large patient population in Asia Pacific region will drive the regional growth. The increasing government spending on healthcare coupled with the rising awareness among the people will drive the regional growth.
Some of the industry players are Becton, Dickinson and Company, Vetter, SCHOTT, Gerresheimer, OMPI, Fresenius Kabi, Medpro, and Nipro. Competing players are taking efforts to develop new products to gain competitive edge. For instance, in September 2016, Fresenius Kabi announced launch of Ketorolac Tromethamine Injection in simplest prefilled syringes.
What Information does this report contain?
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security